Clinical Trials
13
Trial Phases
5 Phases
Drug Approvals
1
Drug Approvals
Clinical Trials
Distribution across different clinical trial phases (12 trials with phase data)• Click on a phase to view related trials
POCone-UBiT-IR300 Pediatric Comparison Study
- Conditions
- Bacterial Infection Due to Helicobacter Pylori (H. Pylori)
- First Posted Date
- 2012-06-19
- Last Posted Date
- 2015-02-23
- Lead Sponsor
- Otsuka America Pharmaceutical
- Target Recruit Count
- 99
- Registration Number
- NCT01623154
- Locations
- 🇺🇸
Miami Pediatric Gastroenterology, Miami, Florida, United States
🇺🇸University of Texas School of Public Health, El Paso, Texas, United States
🇺🇸Baylor College of Medicine, Houston, Texas, United States
Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia
- Conditions
- Euvolemic HyponatremiaHypervolemic Hyponatremia
- First Posted Date
- 2010-11-15
- Last Posted Date
- 2015-05-15
- Lead Sponsor
- Otsuka America Pharmaceutical
- Target Recruit Count
- 5028
- Registration Number
- NCT01240668
- Locations
- 🇺🇸
North America Research Institute, Azusa, California, United States
🇺🇸Chrishard Medical Group, Inglewood, California, United States
🇺🇸UCLA, Los Angeles, California, United States
Study for the Treatment of Crohn's Disease With Adacolumn
- Conditions
- Crohn's Disease
- First Posted Date
- 2005-09-13
- Last Posted Date
- 2009-04-07
- Lead Sponsor
- Otsuka America Pharmaceutical
- Target Recruit Count
- 235
- Registration Number
- NCT00162942
- Locations
- 🇺🇸
Mayo Clinic Scottsdale, Phoenix, Arizona, United States
🇺🇸Capitol Gastroenterology Consultants Medical Group, Roseville, California, United States
🇺🇸UCSF Mount Zion Medical Center, San Francisco, California, United States
Study for the Treatment of Ulcerative Colitis With Adacolumn
- Conditions
- Ulcerative Colitis
- First Posted Date
- 2005-01-25
- Last Posted Date
- 2008-09-08
- Lead Sponsor
- Otsuka America Pharmaceutical
- Target Recruit Count
- 168
- Registration Number
- NCT00102193
- Locations
- 🇺🇸
Mayo Clinic Scottsdale, Phoenix, Arizona, United States
🇺🇸Providence Clinical Research, Burbank, California, United States
🇺🇸University of California, San Francisco, San Francisco, California, United States
Safety and Efficacy of Pletal(Cilostazol) for the Treatment of Juvenile Primary and Secondary Raynaud's Phenomenon
- Conditions
- Raynaud's Disease
- First Posted Date
- 2002-11-11
- Last Posted Date
- 2005-07-19
- Lead Sponsor
- Otsuka America Pharmaceutical
- Target Recruit Count
- 75
- Registration Number
- NCT00048763
- Locations
- 🇺🇸
Advanced Medical Clinical Therapeutics, Anchorage, Alaska, United States
🇺🇸Advanced Medical Research Institute, Fresno, California, United States
🇺🇸Madera Family Medical Group, Madera, California, United States
- Prev
- 1
- 2
- Next